Filing
Spy
Filing
Spy
Home
About
VRTX
Vertex Pharmaceuticals Inc
Biopharmaceutical company
CUSIP: 92532F100
Healthcare
US
1 holder
Ownership
Activity
Fundamentals
2014 Q4
30 of 31 quarters
Total Value
$90.79M
Total Shares
764.2K
Net Share Change
+764.2K
Activity
1 buying
Investor
Value
Shares
Weight
Change
Viking Global Investors
$90.79M
764.2K
0.4%
NEW
Viking Global Investors
$90.79M
764.2K shares
NEW
VRTX — Vertex Pharmaceuticals Inc - FilingSpy